scholarly journals A Black Box Warning: The Marginalization of White-Collar Crime Victimization

2019 ◽  
Vol 1 (1) ◽  
pp. 24-33 ◽  
Author(s):  
Mary Dodge
Keyword(s):  
Drug Administration ◽  
White Collar Crime ◽  
Wide Spectrum ◽  
Food And Drug Administration ◽  
White Collar ◽  
Black Box ◽  
Additional Research ◽  
Crime Victimization ◽  
Street Level ◽  
Victimization Research

The study of white-collar crime has become a subfield of criminology receiving great attention, though victimization calls for additional research. The black box warning, used by the Food and Drug Administration to denote potential serious hazards of a drug or device, is an apt metaphor for the neglect often associated with the identification, depth, consequences, and, at times, violent nature of white-collar crime victimization. Research on victims is evolving, though compared to street-level crime remains marginalized, despite the serious harms caused by the former. This article offers a review of what researchers have accomplished and identifies topics of concern. White-collar crime targets a wide spectrum of the population and a high number of people, but the black box of victimization demonstrates the need for research that further enhances knowledge and informs policy.

Brodalumab for Treatment-Resistant Psoriasis: Case Reports and Safety Update

2020 ◽  
Vol 5 (3) ◽  
pp. 82-85
Author(s):  
Nicholas D. Brownstone ◽  
Vidhatha Reddy ◽  
Quinn Thibodeaux ◽  
Stephanie Chan ◽  
Bridget Myers ◽  
...  
Keyword(s):  
Causal Relationship ◽  
Drug Administration ◽  
Safety Profile ◽  
Case Reports ◽  
Food And Drug Administration ◽  
Black Box ◽  
Interleukin 17 ◽  
Treatment Resistant ◽  
Effective Agent ◽  
Increased Risk

Introduction: Brodalumab is an interleukin-17 receptor blocker that is effective for the treatment of psoriasis. However, due to a Food and Drug Administration black box warning on depression and suicide, many providers are hesitant to use this agent despite its efficacy. Methods: We present the cases of 2 brothers seen at our clinic with treatment-resistant psoriasis who were both successfully treated with brodalumab, despite failing 6 other biologics. We also review the safety profile of brodalumab regarding the currently available evidence on the increased risk of suicidality or depression in patients treated with brodalumab. Results: Both patients achieved completely clear skin and maintained clearance on brodalumab. Discussion: Brodalumab appears to be an effective agent in severe treatment-resistant cases of psoriasis. In addition, a causal relationship between increased risk of suicidality or depression and brodalumab use has not been established.

Allegron and aventyl - nortriptyline

1963 ◽  
Vol 1 (15) ◽  
pp. 57-58
Keyword(s):  
United States ◽  
Drug Administration ◽  
Wide Spectrum ◽  
Food And Drug Administration ◽  
The United States ◽  
Methyl Group ◽  
The Us ◽  
Drug Promotion ◽  
Depressant Drug

Nortriptyline, a new anti-depressant drug, has just been launched simultaneously as a “potent multi-phasic psychotrope, highly predictable in action” (Allegron - Dista), and as a “wide spectrum mood enhancer” (Aventyl - Lilly). Connoisseurs of drug promotion will note that Dista is a subsidiary of Lilly. Nortriptyline has not so far been marketed in the United States, where it was discovered; it has not yet been approved by the US Food and Drug Administration. Chemically the drug closely resembles amitriptyline, differing from it by only one methyl group.

US Food and Drug Administration Black Box Warnings

2020 ◽  
Vol 110 (1) ◽  
Author(s):  
Robert G. Smith
Keyword(s):  
Adverse Effects ◽  
Drug Administration ◽  
Food And Drug Administration ◽  
Black Box ◽  
Ethical Obligation ◽  
Drug Products ◽  
Body Of Knowledge ◽  
Drug Adverse Effects ◽  
Black Box Warnings ◽  
Selection Of

Podiatric Physicians have an ethical obligation to prescribe responsibly and cautiously to diminish and minimize the growth of drug adverse effects. Clinicians who prescribe, dispense, and administer medications must be vigilant in continually reviewing new Black Box Warnings for medications they use for their patients. The safe and appropriate selection of medications and prescribing strategies are presented. First, the concept and process for these FDA black box warnings are introduced. Then, to enrich the podiatric physician's body of knowledge, several FDA boxed warnings from 27 selected drug products that may be prescribed by podiatric physicians are presented graphically as a table. Finally, strategies for safe prescribing of these drugs with boxed warnings are presented.

The Neglected Victims and Unexamined Costs of White-Collar Crime

1990 ◽  
Vol 36 (3) ◽  
pp. 408-418 ◽  
Author(s):  
Elizabeth Moore ◽  
Michael Mills
Keyword(s):  
White Collar Crime ◽  
Moral Character ◽  
White Collar ◽  
Street Crime ◽  
Crime Victimization ◽  
State Programs

In recent years research has documented the victim costs of criminal acts, and a victims' movement has produced federal and state programs to alleviate some of these costs. Although no one disputes that aggregate fiscal costs of white-collar crime dwarf comparable losses from street crime, victimization researchers and the victims' movement have ignored entirely the victims of white-collar crime. This legacy of neglect can be attributed to conservative domination of the victims' agenda and the ambiguous moral character of white-collar victims. This article distinguishes primary and secondary costs of white-collar crime and calls for more research to describe and document them.

Sign in / Sign up

Export Citation Format

Share Document